XADAGO 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
XADAGO 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Commercialized
Register Number
114984003IP3
Prescription Type
Medicamento Sujeto A Prescripción Médica
Authorization Date
Jun 6, 2023
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Route: VÍA ORAL
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number114984003IP3
EMA Approved
Yes
Drug Classification
✗
Generic
No
✗
Orphan
No
✗
Biosimilar
No
✓
Commercialized
Yes
CIMA AEMPS Classification
INGREDIENTS (1)
SAFINAMIDAActive
Quantity: 50 mg
Name: SAFINAMIDA
ATC CLASSIFICATION (3)
N04B
N04BD
N04BD03